- Category
- Micro (2021-22)
- Udyam number
- UDYAM-UP-28-0024670

Wallnis Pharmas Private Limited
About Wallnis Pharmas Private Limited
Data last updated:
Wallnis Pharmas Private Limited is a private limited company based in Noida, Uttar Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 03 August 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24230UP2021PTC150038. Its GSTIN is 20AADCW0220A1ZH (Jharkhand).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Nalin Ranjan Pandey and Mayank Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at E – 208 First Floor E Block Sector 63, Noida, Uttar Pradesh, India – 201307.
As per the financials filed for FY 2025, the company reported a revenue of ₹17.31 Lakh, a decline of 19% compared to the previous year. For the same year it recorded a net loss of ₹87,393 (net margin -5%) and EBITDA of -₹60,099 (EBITDA margin -3.5%). Revenue has grown at a compounded annual rate (CAGR) of 73% over three years.
Wallnis Pharmas Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-28-0024670).
Company details
Recognitions & Rankings of Wallnis Pharmas
Contact details
Wallnis Pharmas Private Limited's registered office is in Noida, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressE – 208 First Floor E Block Sector 63, Noida, Uttar Pradesh, India – 201307
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Wallnis Pharmas Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Wallnis Pharmas is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Wallnis Pharmas Private Limited, buy the company report.
Financials of Wallnis Pharmas Private Limited
FY 2025 filings availableWallnis Pharmas Private Limited reported revenue of ₹17.31 Lakh (down 19% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 19% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 73%. EBITDA fell 359% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹60,099 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹87,393 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -3.5% | |||
| Net Profit Margin | -5% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Wallnis Pharmas Private Limited, buy the company report.
Board of directors of Wallnis Pharmas Private Limited
Wallnis Pharmas has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nalin Ranjan Pandey | Director | 03 Aug 2021 | 5 Years 3 Months | Current |
| Mayank Kumar | Director | 03 Aug 2021 | 5 Years 3 Months | Current |
Peer comparison
Wallnis Pharmas Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Securic Technohouse IT Solutions Private Limited | ₹17.38 Lakh (FY 2023) | -7.0% | Hyderabad, Telangana, India | |||
| Da Crete Chem Private Limited | ₹17.37 Lakh (FY 2022) | 573.0% | Hyderabad, Telangana, India | |||
| Kleanair Enviro Systems Private Limited | ₹17.36 Lakh (FY 2025) | 20.0% | Bangalore, Karnataka, India | |||
| Silver Cap Works Private Limited | ₹17.35 Lakh (FY 2025) | 66.0% | Sivakasi, Tamil Nadu, India | |||
| Anand Herbs India Private Limited | ₹17.31 Lakh (FY 2016) | 13.0% | Bhagalpur, Bihar, India | |||
| Wallnis Pharmas Private Limitedthis company | ₹17.31 Lakh (FY 2025) | -₹87,393 | -5% | -19.0% | Noida, Uttar Pradesh, India | |
| Himed Lifesciences Private Limited | ₹17.29 Lakh (FY 2025) | 7.0% | Kolhapur, Maharashtra, India | |||
| Mitranirmal Meditech Private Limited | ₹17.27 Lakh (FY 2025) | -28.0% | Nachane, Maharashtra, India | |||
| SMN Pharma Private Limited | ₹17.27 Lakh (FY 2025) | 393.0% | Chennai, Tamil Nadu, India | |||
| Modern Health Products Private Limited | ₹17.26 Lakh (FY 2025) | 80.0% | Gwalior, Madhya Pradesh, India | |||
| Zipka Pharmaceuticals Private Limited | ₹17.24 Lakh (FY 2024) | 429.0% | Lucknow, Uttar Pradesh, India |
To see the full peer comparison of Wallnis Pharmas Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Wallnis Pharmas Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Wallnis Pharmas Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Wallnis Pharmas has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 20AADCW0220A1ZH | Jharkhand | Active | 06 Sep 2021 |
To see the full GST registrations and return filing status of Wallnis Pharmas Private Limited, buy the company report.
Recent activity
Wallnis Pharmas Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Mayank Kumar was appointed as Director on 03 Aug 2021.
Frequently asked questions
Wallnis Pharmas is an active private limited company based in Noida, Uttar Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 03 August 2021 (5+ years old) and is registered under CIN U24230UP2021PTC150038.
Wallnis Pharmas has 2 current directors:
- Nalin Ranjan Pandey - Director
- Mayank Kumar - Director
The latest financial statements of Wallnis Pharmas on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Wallnis Pharmas is 20AADCW0220A1ZH, registered in Jharkhand.
The CIN (Corporate Identification Number) of Wallnis Pharmas is U24230UP2021PTC150038. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Wallnis Pharmas was incorporated on 03 August 2021, making it 5+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Wallnis Pharmas by revenue are Securic Technohouse IT Solutions Private Limited, Da Crete Chem Private Limited, Kleanair Enviro Systems Private Limited, Silver Cap Works Private Limited, Anand Herbs India Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Mayank Kumar was appointed as Director on 03 Aug 2021. Nalin Ranjan Pandey was appointed as Director on 03 Aug 2021.
Yes, Wallnis Pharmas is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-28-0024670).
The registered office of Wallnis Pharmas is at E – 208 First Floor E Block Sector 63, Noida, Uttar Pradesh, India – 201307.
Wallnis Pharmas operates in the chemicals industry, in the manufacturing segment.

